Imeglimin Does Not Induce Clinically Relevant Pharmacokinetic Interactions When Combined with Either Metformin or Sitagliptin in Healthy Subjects

被引：0
|
作者：
Pascale Fouqueray
Sandrine Perrimond-Dauchy
Sébastien Bolze
机构：
[1] Poxel SA,
来源：
Clinical Pharmacokinetics | 2020年 / 59卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1261 / 1271
页数：10
相关论文
共 41 条
  • [1] Imeglimin Does Not Induce Clinically Relevant Pharmacokinetic Interactions When Combined with Either Metformin or Sitagliptin in Healthy Subjects
    Fouqueray, Pascale
    Perrimond-Dauchy, Sandrine
    Bolze, Sebastien
    CLINICAL PHARMACOKINETICS, 2020, 59 (10) : 1261 - 1271
  • [2] LACK OF A PHARMACOKINETIC INTERACTION BETWEEN ERTUGLIFLOZIN AND SITAGLIPTIN OR METFORMIN IN HEALTHY SUBJECTS.
    Kumar, V.
    Sahasrabudhe, V.
    Matschke, K.
    Shi, H.
    Alvey, C.
    Fountaine, R. J.
    Hickman, A.
    Saur, D.
    Terra, S. G.
    Zhou, S.
    Krishna, R.
    Cutler, D. L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S47 - S47
  • [3] Daclatasvir Pharmacokinetics in Healthy Subjects: No Clinically-Relevant Drug-Drug Interactions with Either Cyclosporine or Tacrolimus
    Bifano, Marc
    Adamczyk, Robert
    Hwang, Carey
    Kandoussi, Hamza
    Marion, Alan S.
    Bertz, Richard J.
    HEPATOLOGY, 2013, 58 : 730A - 731A
  • [4] Evaluation of pharmacokinetic interactions between lobeglitazone, empagliflozin, and metformin in healthy subjects
    Kim, Heeyoung
    Kim, Choon Ok
    Park, Hyeonsoo
    Park, Min Soo
    Kim, Dasohm
    Hong, Taegon
    Shin, Yesong
    Jin, Byung Hak
    TRANSLATIONAL AND CLINICAL PHARMACOLOGY, 2023, 31 (01) : 59 - 68
  • [5] Absence of clinically relevant pharmacokinetic interaction between ribavirin and tenofovir in healthy subjects
    Ramanathan, S
    Cheng, A
    Mittan, A
    Ebrahimi, R
    Kearney, BR
    JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (05): : 559 - 566
  • [6] No Clinically Relevant Pharmacokinetic and Safety Interactions of Ambrisentan in Combination With Tadalafil in Healthy Volunteers
    Spence, Rebecca
    Mandagere, Arun
    Harrison, Brooke
    Dufton, Christopher
    Boinpally, Ramesh
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 98 (12) : 4962 - 4974
  • [7] Pitavastatin is not subject to clinically relevant pharmacokinetic interactions when administered with CYP3A4 inhibitors in healthy volunteers
    Nakagawa, S.
    Hounslow, N.
    EUROPEAN HEART JOURNAL, 2009, 30 : 958 - 958
  • [8] No clinically significant pharmacokinetic interactions between dolutegravir and daclatasvir in healthy adult subjects
    Ross, Lisa L.
    Song, Ivy H.
    Arya, Niki
    Choukour, Mike
    Zong, Jian
    Huang, Shu-Pang
    Eley, Timothy
    Wynne, Brian
    Buchanan, Ann M.
    BMC INFECTIOUS DISEASES, 2016, 16
  • [9] No clinically significant pharmacokinetic interactions between dolutegravir and daclatasvir in healthy adult subjects
    Lisa L. Ross
    Ivy H. Song
    Niki Arya
    Mike Choukour
    Jian Zong
    Shu-Pang Huang
    Timothy Eley
    Brian Wynne
    Ann M. Buchanan
    BMC Infectious Diseases, 16
  • [10] Administration of tamsulosin with udenafil does not induce clinically significant hypotension in healthy subjects.
    Kim, B. H.
    Kim, J. R.
    Lim, K. S.
    Kim, J. W.
    Kim, M. G.
    Kim, T. E.
    Chung, Y. J.
    Cho, J. Y.
    Yu, K. S.
    Jang, I. J.
    Shin, S. G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S67 - S68
12345